Virginia Contract Research Organization Co., Ltd. (VCRO) professional team has successfully prepared and submitted a Phase I/IIa IND package in common technical document (CTD) format to the US FDA. The Phase I/IIa clinical trial of a small molecule drug for high-grade glioma (a type of brain tumor) treatment has been successfully granted clinical-go by the US FDA on 08/08/2016. The accomplishment has opened a new page of pharmaceutical development in Taiwan and potentially can offer more treatment possibility for patients suffering from brain tumor.
Congratulations! A Phase I/IIa IND of small molecule drug for brain tumor treatment was approved for clinical-go by the USA FDA
Virginia Contract Research Organization Co., Ltd. (VCRO) professional team has successfully prepared and submitted a Phase I/IIa IND package in common technical document (CTD) format to the US FDA. The Phase I/IIa clinical trial of a small molecule drug for high-grade glioma (a type of brain tumor) treatment has been successfully granted clinical-go by the…